Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

INSTITUTE OF LIVER AND BILIARY SCIENCES

Home Clinical Trial Sponsors and OrganizationsINSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES

Sector D 1, Vasant Kunj, New Delhi, Delhi, India

Also known as:

institute of liver and biliary sciences, india

ilbs

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

670

124 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

326

48.7%

Phase 3

33

4.9%

Phase 2/3

26

3.9%

Phase 2

20

3.0%

Unknown

20

3.0%

Phase 4

10

1.5%

Phase 3 4

2

0.3%

Phase 1

1

0.1%

Phase 1/2

1

0.1%

Trial Status Distribution

Active, not recruiting

4

0.6%

Completed

213

31.8%

Not yet recruiting

120

17.9%

Recruiting

240

35.8%

Suspended

4

0.6%

Terminated

3

0.5%

Unknown

66

9.8%

Withdrawn

20

3.0%

Clinical Trials

Trials sponsored by this organization (670)

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial

Not yet recruiting

Jan 2028100 participants

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial

Not yet recruiting

Jan 2027100 participants

To Develop and Validate an Equation for Determination of Major Adverse Kidney Events in Patients With Decompensated Cirrhosis and Ascites.

Aug 2026400 participants

Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant

Jul 202650 participants

Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.

Not yet recruiting

Jun 2026130 participants

Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.

Not yet recruiting

Apr 2026160 participants

Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial

Not yet recruiting

Apr 2026110 participants

Study to see whether adding Midodrine to Carvedilol can better prevent early bleeding again in patients with severe liver disease

Mar 2026210 participants

Page 1 of 84

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials670
Approvals
News

Back to Organizations